Introduction
Mo 1 is a cell surface glycoprotein present on human granulocytes, monocytes, and null cells (1) . It consists of two noncovalently linked proteins of 155,000 and 94,000 molecular masses (2) . Monoclonal antibodies to this antigen and to a similar surface antigen in the mouse and human (Mac-i) specifically inhibit complement C3bi-dependent rosette formation (3, 4) . In addition, anti-Mol blocks phagocytosis by human granulocytes of C3-or IgG-opsonized particles as well as lysosomal enzyme release and superoxide generation by granulocytes in response to opsonized zymosan (3) (Arnaout, M. A., and J. Melamed, unpublished observations). Impaired phagocytosis and opsonized zymosan-induced degranulation and superoxide production were previously noted in granulocytes from a patient with recurrent bacterial infections (5) . The patient's cells were found to be deficient in a surface glycoprotein of molecular mass of -150,000 D (5) . The similarities in the functional defects found in this patient and those produced in normal cells by anti-Mo 1 led us to look for Mo I on the patient's cells to gain more insight into the molecular mechanisms that led to the cellular functional aberrations detected in this patient. We found that: (a) The patient's granulocytes, monocytes, and null cells were deficient in Mo . (b) Mo 1-deficient monocytes had impaired ability to ingest C3-or IgG-coated particles. (c) Rosette formation between the patient's phagocytes and sheep eryth-rocytes coated with C3bi' (a fragment of C3b generated upon cleavage of surface-bound C3b by factors I and H) was totally inhibited by a mixture of anti-Mol and a polyclonal antibody to the receptor for the major cleavage product of C3 (C3b), but not by either antibody alone. (d) Peripheral blood leukocytes (PBL) deficient in Mol had normal natural killing (NK) activity.
Methods
Cell separation. Human neutrophils were prepared from EDTA anticoagulated venous blood by Ficoll-Hypaque centrifugation followed by hypotonic lysis of the erythrocyte pellet (6) . Monocytes were isolated from the interphase mononuclear cell fraction by adherence to plastic petri dishes (1) . A null cell-enriched population was isolated from mononuclear cells by binding of complement fixing monoclonal antibodies to T12 (7), I-2 (8) and Mo2 (1) surface markers (at 1:100 dilutions each, for 30 min at 4VC), followed by complement lysis (rabbit complement, Pel-Freeze Biologicals, Rogers, AR) for 60 min at 370C. These steps depleted T and B lymphocytes and monocytes. The remaining cells were enriched for Mol-positive and Mo2-negative null cells.
Monoclonal antibodies and heteroantisera. Monoclonal antibodies to Mol, Mo2, Mo5, and Mac-I were produced as previously described (9, 10) . The OKM1O monoclonal antibody was obtained from Ortho Pharmaceutical (Raritan, NJ). Two additional monoclonal antibodies to Mol were kindly provided by Dr. J. Griffin, of the Dana Farber Cancer Institute. The F(ab')2 fragment of IgG2a anti-Mol and anti-Mo5 were generated by pepsin digestion followed by gel filtration (I 1). The TS1/18 monoclonal antibody to the 94,000-D subunit of lymphocyte function-associated antigen-l (LFA-1) and Mol/Mac-l/OKMl was produced as described (12 Sheep erythrocytes coated with C3b (EAC43b) were made by first incubating E with rabbit anti-E IgM antibody. This was followed by sequential incubation with guinea pig Cl, human C4, guinea pig C2, and then human C3 as described by Rapp and Borsos (16) . Cl and C2 were allowed to dissociate by 2 h-incubation at 370C in veronal-buffered saline containing 10 mM EDTA.
C3bi-coated sheep erythrocytes (EAC43bi) were made by incubating EAC43b with purified factor I (10 Mg/ml) and factor H (50 Ug/ml) (17) in Hanks' balanced salt solution containing Ca (1.27 mM) and Mg (1.23 mM) (HBSS) for I h at 370C as described (3). Alternatively, EAC43bi
were generated by incubating EAC43b in whole plasma that was extensively preabsorbed with antibody-coated sheep erythrocytes at 0°C. 1.5 X 108 EAC43b cells were incubated with 200 Ml of preabsorbed human EDTA plasma at 1:10 dilution (as a source of factors H and I) for 30 min at 37°C followed by several washes in HBSS containing I mg/ml soybean trypsin inhibitor (Worthington). EAC43bi did not bind to human erythrocytes (18) but rosetted with human granulocytes and monocytes. Rosetting of EAC43bi with normal phagocytes was inhibited by monoclonal antibodies to Mol but not by a rabbit antibody to the human C3b receptor (anti-CRI). C3d-coated sheep erythrocytes (EAC43d) were obtained by incubating EAC43bi with TPCK-trypsin (Millipore Co., Freehold, NJ) at 0.1 g/ ml in PBS for 45 min at 37°C (13) . EAC43d cells did not rosette with human neutrophils but rosetted strongly with Raji cells.
Serum-opsonized lipopolysaccharide-coated oil red O (ORO) particles were prepared as previously described (19) .
Rosetting. Granulocytes and monocytes were kept at 4 X 106/ml in HBSS, 2 mg/ml bovine serum albumin, and I mg/ml soybean trypsin inhibitor (Millipore Corp.). 25 Ml of cells were incubated with 3 Mg F(ab32 anti-Mol, anti-Mo5, or 2 Mg of F(ab)2 anti-CRI for 20 min at room temperature, after which 15 Ml of indicator E at 1.5 X 108/ml were added and the mixture incubated for 40 min at 37°C. To assess rosette formation, the cells were gently resuspended and examined using a hemocytometer. Binding of three or more E to a leukocyte was considered a rosette.
Phagocytosis. One million monocytes suspended in 100,ul ofRPMI-1640 were incubated with or without 5 M&g ofF(ab)2 anti-Mo 1 or control monoclonal antibody for 20 min at room temperature. 50 Ml of EIgG at 2 X 108/ml were then added and the mixture incubated at 37°C for I h. Noningested E were hypotonically lysed with 0.0375 M sodium chloride for 5 s, after which isotonicity was established with 3M sodium chloride (20) . Wright-stained cells were then counted to determine the percentage of cells that ingested one or more E.
Phagocytosis of C3-opsonized ORO particles by patient or control monocytes was performed as previously described (19) .
NK assay. The ability of the patient's PBL to effect NK of the target cell K562 was compared with normal control PBL. K562 cells were labeled with chromium 51 and incubated with PBL at various effector to target cell ratios for 4 h at 370C (21) . Target killing was determined by 51 chromium release into the media. Percent lysis was calculated as previously reported (21) .
Results
Immunoprecipitation ofgranulocyte membrane proteins by monoclonal antibodies. A monoclonal antibody to Mol immunoprecipitated from '25I-surface-labeled normal granulocyte lysates, two noncovalently linked glycoproteins of 155 and 94 kD (Fig. 1 A) . By using this same antibody, no bands were immunoprecipitated from the patient's '25I-labeled granuloctyes (Fig. 1 A) . This monoclonal anti-Mo reacts only with the 155-kD glycoprotein (3). To determine if the patient's cells were also missing the 94-kD subunit, a monoclonal antibody reactive with the 94-kD subunit of Mo I/OKM was used. This anti-94-kD antibody immunoprecipitated from normal cells the two subunits of Mo as well as two other surface proteins which share the same 94-kD subunit with OKM 1/Mo 1, namely LFA-1 (subunits of 177 and 95 kD) and P-150,95 (subunits of 150 and 95 kD) (Fig. 1 B, lanef) (22) . No radiolabeled bands were seen with the patient's cells (Fig. I B, lane c) . These data demonstrate that the surface of the patient's granulocytes is deficient in both the 155 and 94 kD polypeptides of Mol antigen as determined by subunit-specific monoclonal antibodies. To determine if the patient's neutrophils totally lack Mol, a more sensitive radioimmunoassay was used (3). Increasing amounts of '25I-Fab' anti-Mol were incubated with the patient's granulocytes in the absence or presence of unlabeled Fab' anti-Mo (100-fold molar excess). Scatchard analysis of the binding data revealed that the patient has 7,000±3,000 Mol sites/cell (mean±SD) vs 65,000±7,000 (mean±SD) for granulocytes from nine random individuals. These data indicate that the patient is deficient but not totally lacking the 155-kD subunit of Mo .
Analysis of cell surface antigens by immunofluorescence. Fluorescence analysis confirmed that the patient's granulocytes were deficient in Mo 1, but expressed normal amounts of other leukocyte markers including Mo5, J5, and beta2-microglobulin (data not shown). The patient's granulocytes were also deficient in the equivalent Mac-1 antigen (data not shown). The patient's monocytes and null cells were also deficient in Mo when studied by indirect immunofluorescence technique. As can be seen in Fig. 2 , immunofluorescent staining with anti-Mo2 (a monocytespecific surface marker) ofboth the patient's and control monocytes were comparable; yet, only the control monocytes had detectable staining with anti-Mo 1. Similarly, no anti-Mo 1 staining was detected on the patient's null cell population. This population was defined by selecting the mononuclear cells which were T12-, Ia-, and Mo2-negative as described in Methods. A similar null cell population, which was isolated in parallel from normal control blood, had detectable immunofluorescent staining with the anti-Mo antibody (Fig. 2 B) .
The (Table II) , a finding similar to that noted in his granulocytes (5) . Ingestion of EIgG by patient's monocytes was also significantly reduced (Table II) . Normal monocytes treated with anti-Mo 1 showed a similar impairment in ingestion of serum-opsonized ORO or of EIgG. Inhibition of IgG phagocytosis was more striking at low IgG input (data not shown).
Since PBL enriched for null cells were deficient in Mol expression, it was of interest to determine if this deficiency was associated with an impairment of NK, a function attributed to Ml (Mo 1) positive null cells (23) . Both patient and control cells mediated comparable degrees of lysis against K562 target cells indicating that deficiency of surface Mo 1 does not alter the cells ability to perform NK (Fig. 3) .
Discussion
Several patients with recurrent bacterial infections associated with deficiencies of granulocyte proteins have been described (5, 24, 25, 26) . We used monoclonal antibodies to further characterize the functional defects in our patient. This study demonstrates the deficiency of a surface membrane glycoprotein, Mo (Table II) . NK activity by the patient's PBL was normal (Fig. 3) , in agreement with in vitro studies in which pretreating PBL with anti-Mac-l (27) On normal cells, anti-Mo 1, anti-Mac-I or anti-OKM10 effectively blocked C3bi receptor-depedent rosette formation suggesting that Mol/Mac-l/OKMl are closely associated (3, 4) or identical (28) with the C3bi receptor. It has also been suggested that EAC43bi can bind to the C3b receptor (29, 30, 31 Structural studies revealed that the patient's cells were deficient in the two subunits of Mol antigen (Fig. 1) . A monoclonal (3) . Of interest is that LFA-1, a structurally similar molecule, appears to serve such a function on lymphocytes (12, 32) .
The anti-Mo 1-induced functional defects on normal phagocytes were similar to those observed in Mo 1-deficient cells. These findings suggest an association between deficiency ofthe 155,000-D piece of Mol and the observed functional defects seen in the patient's phagocytes. However, it should be noted that if deficiency of the 94-kD subunit is the primary defect, this may have a pleiotropic effect. The 94 kD is common to three different surface antigens: Mol, LFA-1, and P150,95. Immunoprecipitation studies indicate that at least two and possibly all three are deficient from the patient's granulocytes. It is possible that deficiency of these additional glycoproteins could also contribute to the observed functional defects. Harrison, and P. J. Lachmann, manuscript submitted for publication).
